$250 | Single User
$500 | Site License
$750 | Global License

Brickell Biotech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 13-04-2018]

Published by Global Data: 13 Apr 2018 | 207677 | In Stock

Introduction

Summary

Brickell Biotech Inc (Brickell Biotech) is a pharmaceutical company that develops differentiated therapeutics for the treatment of skin diseases. The company offers pipeline product candidates such as BBI-4000, BBI-5000, BBI-2000, BBI-3000 and BBI -6000. Its product candidate BBI-4000 is an anticholinergic used for the treatment of primary axillary hyperhidrosis; BBI-5000, a selective oral immunomodulator for moderate to severe atopic dermatitis. Brickell Biotech's BBI-2000, is an anti-inflammatory peptide in pre-clinical stage for contact dermatitis, and BBI-3000, a potent topical and oral retinoid in pre-clinical stage for the treatment of acne. The company serves cosmetic and aesthetics companies, pharmaceutical and healthcare companies. Brickell Biotech is headquartered in Boulder, Colorado, the US.

Brickell Biotech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Brickell Biotech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 13-04-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 4

    List of Figures 4

    Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

    Brickell Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

    Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

    Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

    Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

    Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deal Details 10

    Asset Purchase 10

    Brickell Biotech Acquires Rights to RORy Inhibitors from Orca Pharma 10

    Venture Financing 11

    Brickell Biotech Raises USD10 Million in Series C Financing 11

    Brickell Biotech Raises US Million In Series B Financing 12

    Licensing Agreements 13

    Brickell Biotech Enters into Licensing Agreement with Kaken Pharma 13

    Brickell Biotech Enters into Licensing Agreement with Merz North America for BBI-3000 14

    Brickell Biotech Enters into Licensing Agreement with Bodor Labs 15

    Argyle Therapeutics Enters Into Licensing Agreement With Brickell Biotech For Rosacea Drug 16

    Brickell Biotech Inc - Key Competitors 17

    Brickell Biotech Inc - Key Employees 18

    Brickell Biotech Inc - Locations And Subsidiaries 19

    Head Office 19

    Appendix 20

    Methodology 20

    About GlobalData 20

    Contact Us 20

    Disclaimer 20

List Of Tables
in Brickell Biotech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 13-04-2018]

List of Tables

Brickell Biotech Inc, Pharmaceuticals & Healthcare, Key Facts 2

Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Brickell Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Brickell Biotech Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Brickell Biotech Acquires Rights to RORy Inhibitors from Orca Pharma 10

Brickell Biotech Raises USD10 Million in Series C Financing 11

Brickell Biotech Raises US Million In Series B Financing 12

Brickell Biotech Enters into Licensing Agreement with Kaken Pharma 13

Brickell Biotech Enters into Licensing Agreement with Merz North America for BBI-3000 14

Brickell Biotech Enters into Licensing Agreement with Bodor Labs 15

Argyle Therapeutics Enters Into Licensing Agreement With Brickell Biotech For Rosacea Drug 16

Brickell Biotech Inc, Key Competitors 17

Brickell Biotech Inc, Key Employees 18

List Of Figures, Charts and Diagrams
in Brickell Biotech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 13-04-2018]

List of Figures

Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Brickell Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Additional Details

Publisher

Global Data

Publisher Information

Reference

207677 | GDPH265192D

Number of Pages

20

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Brickell Biotech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryBrickell Biotech Inc (Brickell Biotech) is a pharmaceutical company that develops differentia...
27 Feb 2018 by Global Data USD $250 More Info
Brickell Biotech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryBrickell Biotech Inc (Brickell Biotech) is a pharmaceutical company that develops differentia...
08 Nov 2017 by Global Data USD $250 More Info
Brickell Biotech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryBrickell Biotech Inc (Brickell Biotech) is a clinical-stage therapeutics development company ...
25 Jul 2017 by Global Data USD $250 More Info
Brickell Biotech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryBrickell Biotech Inc (Brickell Biotech) is a clinical-stage therapeutics development company ...
10 Mar 2017 by Global Data USD $250 More Info
Brickell Biotech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryBrickell Biotech Inc (Brickell Biotech) is a clinical-stage therapeutics development company ...
23 Feb 2017 by Global Data USD $250 More Info
Brickell Biotech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryBrickell Biotech Inc (Brickell Biotech) is a clinical-stage pharmaceutical company that focus...
24 Nov 2016 by Global Data USD $250 More Info
Brickell Biotech, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryBrickell Biotech, Inc. (Brickell Biotech) is a clinical-stage pharmaceutical company that foc...
24 Aug 2016 by Global Data USD $250 More Info
Brickell Biotech, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryBrickell Biotech, Inc. (Brickell Biotech) is a clinical-stage pharmaceutical company that foc...
05 May 2016 by Global Data USD $250 More Info
Brickell Biotech, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryBrickell Biotech, Inc. (Brickell Biotech) is a clinical-stage pharmaceutical company that foc...
09 Mar 2016 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Brickell Biotech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 13-04-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data